Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency

被引:21
作者
di San Filippo, CA
Wang, YH
Longo, N
机构
[1] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA
[3] Emory Univ, Dept Pediat, Div Med Genet, Atlanta, GA 30222 USA
关键词
D O I
10.1074/jbc.M307911200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation characterized by hypoketotic hypoglycemia and skeletal and cardiac myopathy. It is caused by mutations in the Na+-dependent organic cation transporter, OCTN2. To define the domains involved in carnitine recognition, we evaluated chimeric transporters created by swapping homologous domains between OCTN1, which does not transport carnitine, and OCTN2. Substitution of the C terminus of OCTN2 ( amino acid residues 342-557) with the corresponding residues of OCTN1 completely abolished carnitine transport. The progressive substitution of the N terminus of OCTN2 with OCTN1 resulted in a decrease in carnitine transport associated with a progressive increase in the Km toward carnitine from 3.9 +/- 0.5 to 141 +/- 19 muM. The largest drop in carnitine transport ( and increase in Km toward carnitine) was observed with the substitution of residues 341-454 of OCTN2. An additional chimeric transporter (CHIM-9) in which only residues 341-454 of OCTN2 were substituted by OCTN1 had markedly reduced carnitine transport, with an elevated Km toward carnitine (63 +/- 5 muM). Site-directed mutagenesis and introduction of residues nonconserved between OCTN1 and OCTN2 in the OCTN2 cDNA indicated that the R341A, L409W, L424Y, and T429I substitutions significantly decreased carnitine transport. Single substitutions did not increase the Km toward carnitine. By contrast, the combination of three of these substitutions (R341W + L409W + T429I) greatly decreased carnitine transport and increased the Km toward carnitine (20.2 +/- 4.5 muM). The Arg-341, Leu-409, and Thr-429 residues are all located in predicted transmembrane domains. Involvement of these residues in carnitine transport was further supported by the partial restoration of carnitine transport by the introduction of these OCTN2 residues in the OCTN1 portion of CHIM-9. These studies indicate that multiple domains of the OCTN2 transporter are required for carnitine transport and identify transmembrane residues important for carnitine recognition.
引用
收藏
页码:47776 / 47784
页数:9
相关论文
共 25 条
[1]   Molecular identification of a novel carnitine transporter specific to human testis - Insights into the mechanism of carnitine recognition [J].
Enomoto, A ;
Wempe, MF ;
Tsuchida, H ;
Shin, HJ ;
Cha, SH ;
Anzai, N ;
Goto, A ;
Sakamoto, A ;
Niwa, T ;
Kanai, Y ;
Anders, MW ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36262-36271
[2]   Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in substrate recognition [J].
Feng, B ;
Shu, Y ;
Giacomini, KM .
BIOCHEMISTRY, 2002, 41 (28) :8941-8947
[3]   Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3 [J].
Feng, B ;
Dresser, MJ ;
Shu, Y ;
Johns, SJ ;
Giacomini, KM .
BIOCHEMISTRY, 2001, 40 (18) :5511-5520
[4]   Membrane localization of the electrogenic cation transporter rOCT1 in rat liver [J].
Meyer-Wentrup, F ;
Karbach, U ;
Gorboulev, V ;
Arndt, P ;
Koepsell, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :673-678
[5]   Na+- and Cl- -coupled active transport of carnitine by the amino acid transporter ATB0,+ from mouse colon expressed in HRPE cells and Xenopus oocytes [J].
Nakanishi, T ;
Hatanaka, T ;
Huang, T ;
Prasad, PD ;
Leibach, FH ;
Ganapathy, ME ;
Ganapathy, V .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 532 (02) :297-304
[6]   Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein [J].
Ohashi, R ;
Tamai, I ;
Inano, A ;
Katsura, M ;
Sai, Y ;
Nezu, JI ;
Tsuji, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) :1286-1294
[7]   Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2 [J].
Ohashi, R ;
Tamai, I ;
Nezu, J ;
Nikaido, H ;
Hashimoto, N ;
Oku, A ;
Sai, Y ;
Shimane, M ;
Tsuji, A .
MOLECULAR PHARMACOLOGY, 2001, 59 (02) :358-366
[8]   Functional characterization of the carnitine transporter defective in primary carnitine deficiency [J].
Scaglia, F ;
Wang, YH ;
Longo, N .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 364 (01) :99-106
[9]   Primary and secondary alterations of neonatal carnitine metabolism [J].
Scaglia, F ;
Longo, N .
SEMINARS IN PERINATOLOGY, 1999, 23 (02) :152-161
[10]  
Segel I. H., 1975, Enzyme Kinetics, P274